Pharmacy News

FDA issues EUA for new COVID-19 treatment

On Saturday, FDA issued an emergency use authorization (EUA) for a combination monoclonal antibody treatment—casirivimab and imdevimab (Regeneron Pharmaceuticals)—to be administered together for the treatment of mild to moderate COVID-19 in adults and pediatric patients aged 12 years and older weighing 88 pounds with positive results of direct SARS-CoV-2 viral testing and who are at high risk for progressing to severe COVID-19.

Pfizer to seek authorization of COVID-19 vaccine Friday

Pfizer announced that it plans to ask FDA on Friday for emergency use authorization of its COVID-19 vaccine. Pfizer and partner BioNTech reported this week the two-dose vaccine was 95% effective and well-tolerated.

Oxford, AstraZeneca coronavirus vaccine's strong response in older adults confirmed in review

Older adults responded favorably to AstraZeneca's COVID-19 vaccine, according to Phase II peer-reviewed results reported in The Lancet.

Pfizer says vaccine is 95% effective in final data, will seek authorization

Pfizer and BioNTech reported Wednesday their experimental COVID-19 vaccine was 95% effective in the final results of a key study. According to the companies, Pfizer intends to seek FDA authorization for the vaccine within days.

Amid concerns about declining childhood vaccination rates, measles surges globally

Even before the COVID-19 pandemic drowned out every other public health issue, global measles cases reached a 23-year high, according a new World Health Organization (WHO) and CDC publication released on November 13. In 2019, there were a reported 869,770 measles cases leading to 207,500 deaths. The death rate was 50% higher than it was in 2016. Now, amid a worldwide coronavirus-related decline in childhood vaccinations, the agencies warn that global immunization partners must act quickly to reverse the trend.